Molecular Genetic Markers of Ovarian Cancer
Clinical Trials and Bioavailability Research · 18.07.2026 · 4 (1)
DOI: 10.58489/2836-5836/014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Trials and Bioavailability Research, online erschienen am 18.07.2026. Verfasst von BON L.I..
Abstract (Originalsprache)
Ovarian cancer (OC) is a collective term for a group of diseases that differ in their morphological and molecular characteristics and represent one of the leading causes of death among patients with gynecological malignancies. The insufficient accuracy of standard diagnostic methods necessitates the search for new, more convenient, and precise techniques. This article reviews recently discovered ovarian cancer biomarkers, the theoretical foundations for their application, and their clinical significance. The need for further research into novel markers and the integration of existing ones into clinical practice is highlighted.
Zitieren
APA
L.I., B. (2026). Molecular Genetic Markers of Ovarian Cancer. Clinical Trials and Bioavailability Research, 4(1). https://doi.org/10.58489/2836-5836/014
Vancouver
L.I. B. Molecular Genetic Markers of Ovarian Cancer. Clinical Trials and Bioavailability Research. 2026;4(1). doi:10.58489/2836-5836/014
BibTeX
@article{LI2026,
author = {L.I., BON},
title = {Molecular Genetic Markers of Ovarian Cancer},
journal = {Clinical Trials and Bioavailability Research},
year = {2026},
volume = {4},
number = {1},
doi = {10.58489/2836-5836/014}
}
EUVIMED